Explore UAB

Gastroenterology & Hepatology

Forging the future of gastroenterology and hepatology

The UAB Division of Gastroenterology and Hepatology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most advanced care.

OUR PROGRAMS

Preparing the next generation of physicians and scientists

We're dedicated to nurturing and guiding the future generation of physicians and physician-scientists, recognizing that our trainees are the cornerstone of our nation's healthcare system.

OUR PEOPLE

Home to leading experts and distinguished scholars

Our faculty, staff, and trainees play an exceptionally critical role in shaping the future of healthcare through their expertise in education, research, and clinical practice, driving innovation and excellence.

Latest Headlines

  • UAB receives renewed funding for colorectal cancer screening project
    Nov 18, 2024
  • UAB celebrates milestone with 3,000 adult liver transplants
    Sep 26, 2024
  • UAB Hospital continues to be the best hospital in Alabama, Birmingham metro, according to U.S. News & World Report
    Jul 16, 2024
  • UAB to offer free colonoscopy screenings to under- and uninsured for second consecutive year
    May 21, 2024

Daniel C. Bullard, Ph.D.
Associate Professor of Genetics
Phone:
 (205) 934-7768 
E-mail:
 pike@uab.edu 

bullard


Dr. Bullard received his undergraduate degree in zoology from Iowa State University and his Ph.D. in genetics from Case Western Reserve University.  During his postdoctoral studies in the Department of Human and Molecular Genetics at Baylor College of Medicine in Houston, he initiated research investigating the role of leukocyte/endothelial cell adhesion molecules in inflammatory processes. He joined the Department of Genetics at UAB in 1996.

Dr. Bullard’s research interests are centered on defining the mechanisms that regulate inflammation. For these investigations, we have focused our studies on defining the roles of leukocyte/endothelial cell adhesion molecules in mediating inflammatory responses. These proteins, along with chemoattractant/activating molecules, mediate the process by which leukocytes exit the vasculature into tissue in response to an inflammatory stimulus. Many different adhesion molecules have been described, including the selectins, integrins, and members of the immunoglobulin superfamily of adhesion receptors. Recent evidence from our lab and others suggest that these molecules play both pro- and anti-inflammatory roles, and we are using a genetic approach in mice to further define these functions. For our studies, we have developed many different lines of adhesion molecule mutant mice using gene-targeting methodologies. Mice with single or multiple mutations are currently being analyzed in models of rheumatoid arthritis, lupus erythematosus, vasculitis, and inflammatory bowel disease to determine their specific roles in the pathogenesis of these diseases. Our lab has also characterized a novel model for psoriasis and psoriatic arthritis that develops in Beta-2 integrin mutant mice backcrossed onto the PL/J strain background. We are now trying to map and clone the genes that control the development of both the skin disease and the arthritis in this model system.

Selected Publications

  1. Kevil, C.G., Patel, R.P. and Bullard, D.C. Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am. J. Physiol. Cell Physiol. 281:C1442-C1447, 2001.
  2. Kevil, C.G. and Bullard, D.C. In vitro culture and characterization of gene targeted mouse endothelium. Acta Physiol. Scan. 173:151-158, 2001.
  3. Reinhardt, R.L., Bullard, D.C., Weaver, C.T., and Jenkins, M.K. Effector CD4 T cells accumulate preferentially at the antigen injection site during the primary response via CD62E-dependent mechanism but do not proliferate. J. Exp. Med. 197:751-762, 2003.
  4. Barlow, S.C., Collins, R.C., Lindsey, J.R., Weaver, C.T., Schoeb, T.R., and Bullard, D.C. The development of dermatitis in Itgb2tm1Bay mice requires low level Itgb2 expression and at least two different PL/J loci for severe disease. Amer. J. Pathol. 163:197-202, 2003.
  5. Barlow, S.C., Xu, H., Weaver, C.T., Lindsey, J.R., Schoeb, T.R. and Bullard, D.C. Psoriasiform dermatitis in CD18 deficient PL/J mice is a mediated by both CD4+ and CD8+ T lymphocytes. Int. Immunol. 16:345-351, 2004.
  6. Clark, J.G., Mandac, J.B., Dixon, A.E., Madtes, D.K., Burkhart, K., Martin, P.J., Harlan, J.M. and Bullard, D.C. Trafficking of Th1 cells to lung: A role for selectins and a PSGL-1 independent ligand. Amer. J. Respir. Cell Mol. Biol. 30:220-227, 2004.
  7. Kevil, C.G., Orr, A.W., Langston, W., Mickett, K., Murphy-Ullrich, J., Patel, R.P., Kucik, D.F. and Bullard, D.C. ICAM-1 regulates endothelial cell motility through an NO dependent pathway. J. Biol. Chem.279:19230-19238, 2004.
  8. Kevil, C.G., Hicks, M.J., He, X., Zhang, X., Ballantyne, C.M., Raman, C., Schoeb, T.R. and Bullard, D.C. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Faslpr mice from autoimmune disease. Amer. J. Pathol. 165:609-616, 2004.